FDA Approved: ADBRY — Original Application (LEO Pharma Inc.)

View source ↗

Summary

FDA approved ADBRY (tralokinumab-ldrm) through an original Biologics License Application filed by LEO Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ADBRY (TRALOKINUMAB-LDRM)

Snippet

ORIG AP for ADBRY (TRALOKINUMAB-LDRM)